Table 3.

IL-17 responses in patients with active TB (ATB) compared to latent tuberculosis infection (LTBI).

	Increased in ATB	No difference	Reduced in ATB
% of IL-17+CD4+ T-cells
Short incubation (0–48 h)	Basile et al. (183)a	Marin et al. (184, 185)	Scriba et al. (175); Perreau et al. (186)
Long incubation (72–144 h)	Jurado et al. (187); Marin et al. (184)	Cowan et al. (174); Marin et al. (185)	Perreau et al. (186); Heidarnezhad et al. (188)
Ex vivo IL-17 production	Jurado et al. (187); Xu et al. (189)	Sargentini et al. (190); Cowan et al. (174); Kim et al. (191)	Kumar et al. (192); Nunnari et al. (193); Bandaru et al. (182)

^aOnly in MDR-TB.